The association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis
<p>Abstract</p> <p>Background</p> <p>There have been inconsistent results from case-control studies assessing the association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease (CHD). Most studies have included predominantly men and the asso...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-06-01
|
Series: | BMC Genetics |
Online Access: | http://www.biomedcentral.com/1471-2156/5/17 |
id |
doaj-12885fa745dd495b9a7271ebfaaa2067 |
---|---|
record_format |
Article |
spelling |
doaj-12885fa745dd495b9a7271ebfaaa20672020-11-25T03:25:09ZengBMCBMC Genetics1471-21562004-06-01511710.1186/1471-2156-5-17The association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysisKiessling MatthewBriggs Patricia JHinks Lesley JGaunt Tom RDay Ian NMLawlor Debbie ATimpson NickSmith GeorgeEbrahim Shah<p>Abstract</p> <p>Background</p> <p>There have been inconsistent results from case-control studies assessing the association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease (CHD). Most studies have included predominantly men and the association in women is unclear. Since lipid levels vary between the sexes the antioxidant effect of PON1 and any genes associated with it may also vary by sex. We have examined the association of the <it>PON1 </it>Q192R polymorphism with CHD in a large cohort of British women and combined the results from our cohort study with those from all other published studies.</p> <p>Results</p> <p>The distribution of genotypes was the same among women with CHD and those without disease. The odds ratio (95% confidence interval) of having CHD comparing those with either the QR or RR genotype to those with QQ genotype (dominant model of association) was 1.03 (0.89, 1.21) and the per allele odds ratio was 0.98 (0.95, 1.01). In a meta-analysis of this and 38 other published studies (10,738 cases and 17,068 controls) the pooled odds ratio for the dominant effect was 1.14 (1.08, 1.20) and for the per allele effect was 1.10 (1.06, 1.13). There was evidence of small study bias in the meta-analyses and the dominant effect among those studies with 500 or more cases was 1.05 (0.96, 1.15). Ethnicity and reporting of whether the genotyping was done blind to the participants clinical status also contributed to heterogeneity between studies, but there was no difference in effect between studies with 50% or more women compared to those with fewer women and no difference between studies of healthy populations compared to those at high risk (with diabetes, renal disease of familial hypercholesterolaemia).</p> <p>Conclusion</p> <p>There is no robust evidence that the <it>PON1 </it>Q192R polymorphism is associated with CHD risk in Caucasian women or men.</p> http://www.biomedcentral.com/1471-2156/5/17 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kiessling Matthew Briggs Patricia J Hinks Lesley J Gaunt Tom R Day Ian NM Lawlor Debbie A Timpson Nick Smith George Ebrahim Shah |
spellingShingle |
Kiessling Matthew Briggs Patricia J Hinks Lesley J Gaunt Tom R Day Ian NM Lawlor Debbie A Timpson Nick Smith George Ebrahim Shah The association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis BMC Genetics |
author_facet |
Kiessling Matthew Briggs Patricia J Hinks Lesley J Gaunt Tom R Day Ian NM Lawlor Debbie A Timpson Nick Smith George Ebrahim Shah |
author_sort |
Kiessling Matthew |
title |
The association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis |
title_short |
The association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis |
title_full |
The association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis |
title_fullStr |
The association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis |
title_full_unstemmed |
The association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis |
title_sort |
association of the <it>pon1 </it>q192r polymorphism with coronary heart disease: findings from the british women's heart and health cohort study and a meta-analysis |
publisher |
BMC |
series |
BMC Genetics |
issn |
1471-2156 |
publishDate |
2004-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>There have been inconsistent results from case-control studies assessing the association of the <it>PON1 </it>Q192R polymorphism with coronary heart disease (CHD). Most studies have included predominantly men and the association in women is unclear. Since lipid levels vary between the sexes the antioxidant effect of PON1 and any genes associated with it may also vary by sex. We have examined the association of the <it>PON1 </it>Q192R polymorphism with CHD in a large cohort of British women and combined the results from our cohort study with those from all other published studies.</p> <p>Results</p> <p>The distribution of genotypes was the same among women with CHD and those without disease. The odds ratio (95% confidence interval) of having CHD comparing those with either the QR or RR genotype to those with QQ genotype (dominant model of association) was 1.03 (0.89, 1.21) and the per allele odds ratio was 0.98 (0.95, 1.01). In a meta-analysis of this and 38 other published studies (10,738 cases and 17,068 controls) the pooled odds ratio for the dominant effect was 1.14 (1.08, 1.20) and for the per allele effect was 1.10 (1.06, 1.13). There was evidence of small study bias in the meta-analyses and the dominant effect among those studies with 500 or more cases was 1.05 (0.96, 1.15). Ethnicity and reporting of whether the genotyping was done blind to the participants clinical status also contributed to heterogeneity between studies, but there was no difference in effect between studies with 50% or more women compared to those with fewer women and no difference between studies of healthy populations compared to those at high risk (with diabetes, renal disease of familial hypercholesterolaemia).</p> <p>Conclusion</p> <p>There is no robust evidence that the <it>PON1 </it>Q192R polymorphism is associated with CHD risk in Caucasian women or men.</p> |
url |
http://www.biomedcentral.com/1471-2156/5/17 |
work_keys_str_mv |
AT kiesslingmatthew theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT briggspatriciaj theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT hinkslesleyj theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT gaunttomr theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT dayiannm theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT lawlordebbiea theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT timpsonnick theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT smithgeorge theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT ebrahimshah theassociationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT kiesslingmatthew associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT briggspatriciaj associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT hinkslesleyj associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT gaunttomr associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT dayiannm associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT lawlordebbiea associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT timpsonnick associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT smithgeorge associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis AT ebrahimshah associationoftheitpon1itq192rpolymorphismwithcoronaryheartdiseasefindingsfromthebritishwomensheartandhealthcohortstudyandametaanalysis |
_version_ |
1724598753466253312 |